StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) stock

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.17−0.06 (-23.91%)

Close on Nov 20, 2026Market cap $2.69MP/E –Yield –

Traws Pharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Traws Pharma

Traws Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Traws Pharma figures

See a number that looks wrong?